Lyme Disease Prophylaxis by Single-Dose Doxycycline in the United States, 2010-2020
- PMID: 39474446
- PMCID: PMC11521345
- DOI: 10.1093/ofid/ofae593
Lyme Disease Prophylaxis by Single-Dose Doxycycline in the United States, 2010-2020
Abstract
Single-dose doxycycline after high-risk tick bites can prevent Lyme disease, which disproportionately affects children. We described single-dose doxycycline dispensings in an outpatient cohort in the United States. During 2010-2020, a total of 427 105 patients received ≥1 dispensing(s); most were aged ≥65 years. Lyme disease postexposure prophylaxis may be underprescribed for some groups, including children.
Keywords: Lyme disease; PEP; doxycycline; postexposure prophylaxis; tick bite.
Published by Oxford University Press on behalf of Infectious Diseases Society of America 2024.
Conflict of interest statement
Potential conflicts of interest. The authors: No reported conflicts of interest.
References
-
- Kache PA, Bron GM, Zapata-Ramirez S, et al. Evaluating spatial and temporal patterns of tick exposure in the United States using community science data submitted through a smartphone application. Ticks Tick Borne Dis 2023; 14:102163. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
